Decree of the Ministry of Health No. 209 / 1998 Coll.
Decree of the Ministry of Health amending Decree of the Ministry of Health No. 57 / 1997 Coll., which provides for medicinal products fully covered by health insurance and the amount of payments of individual active substances, as amended
Valid
Order
Effective from 01.10.1998
Text versions:
01.10.1998
07.09.1998
Zobrazeno prvních 200 z celkem 387 ustanovení tohoto předpisu.
Zobrazit celý předpis →
Pro stažení celého znění použijte tlačítko Stáhnout výše.
209
DECLARATION
Ministry of Health
of 27 August 1998
amending Decree of the Ministry of Health No 57 / 1997 Coll., laying down the medicinal products fully covered by the health insurance and the amount of the payments of the individual active substances, as amended
According to § 15 (5) of Act No. 48 / 1997 Coll., on Public Health Insurance and on the amendment and addition of certain related laws, the Ministry of Health provides for:
Decree No 57 / 1997 Coll., laying down the medicinal products fully covered by the health insurance and the amount of the payments of individual active substances, as amended by Decree No 109 / 1997 Coll., No 131 / 1997 Coll., No 220 / 1997 Coll., No 317 / 1997 Coll., No 72 / 1998 Coll. and No 133 / 1998 Coll., Annex Section B is amended as follows:
1. row 45.2 reads as follows:
| „45.2 | A10AA | insuliny (rozpustné humánní) | parent. | 40 | U | 20,30 | L/DIA“. |
2. row 46.1 reads as follows:
| „46.1 | A10AA | insuliny (rozpustné monokomponentní) | parent. | 40 | U | 16,90 | “. |
3. Row 47.2 reads:
| „47.2 | A10AA | insuliny (suspenzní humánní) | parent. | 40 | U | 20,30 | L/DIA“. |
4. Row 48.1 reads:
| „48.1 | A10AA | insuliny (suspenzní monokomponentní) | parent. | 40 | U | 12,95 | “. |
5. the following row 56.2 is inserted after row 56.1:
| „56.2 | A11CC05 | cholekalciferol parenterální | parent. | 1 | kU | 0,95 | “. |
6. Line 83.5 reads:
| „83.5 | B02BC | lokální hemostatin (karboxycelulosa) | lok. | 1 | GM | 15,75 | “. |
7. the following rows 84.10 and 84.11 are inserted after row 84.9:
| „84.10 | B02BD02 | koagulační faktor VIII středně čištěný s von Willebrandovým faktorem | parent. | 500 | U | 8000,00 | B/P |
| 84,11 | B02BD02 | koagulační faktor VIII vysoce čištěný s von Wilebrandovým faktorem | parent. | 500 | U | 8750,00 | B/P “. |
8. the following is inserted after row 84.11:
"To treat bleeding conditions caused by von Willebrand's disease."
9. rows 85.2 and 85.6 are deleted.
10. the following row 95.16 is inserted after row 95.15:
| „95.16 | B05BA03 | glukóza inj. 40% (do 10 ml včetně v jedné ampuli ) | parent. | 100 | ML | 100,90 | O“. |
11. the following entry 00471 is inserted after row 95.16:
| „00471 | GLUCOSUM LECIVA 40% | inj 10x10ml 40% | LEX | CZ“. |
12. the following row 97.4 is inserted after row 97.3:
| „97.4 | B05BB01 | chlorid sodný 0.9% (do 10 ml včetně v jedné ampuli) | parent. | 100 | ML | 43,80 | O“. |
13. the following entry 96886 is inserted after row 97.4:
| „96886 | 0.9% W/V SODIUM CHLORIDE I.V. | inj 20x10ml | BME | D“. |
14. after row 111.2, entries 91276 and 91277 are deleted:
| „91276 | PROLEKOFEN | tbl fc 50x150mg | LEK | SLO |
| 91277 | PROLEKOFEN | tbl fc 50x300mg | LEK | SLO“. |
15. Line 111.2 reads:
| „111.2 | C01BC03 | propafenon (méně než 100 mg v jedné tabletě) | p.o. | 0,3 | GM | 18,10 | “. |
16. the following entry 76761 is inserted after row 111.2:
| „76761 | RYTMONORM 10MG | tbl obd 500x10mg | KNO | D“. |
17. the following row 114.4 is inserted after row 114.3:
| „114.4 | C01BD05 | ibutilid | parent. | 1 | MG | 3800,- | H“. |
18. the following row 157.4 is inserted after row 157.3:
| „157.4 | C07BB07 | bisoprolol a thiazidy | p.o. | 1 | DF | 3,80 | “. |
19. Line 160.2 reads:
| „160.2 | C08DA01 | verapamil (retardované lékové formy s obsahem 240 mg) | p.o. | 0.24 | GM | 6,05 | “. |
20. After row 160.2, entry 93679 is deleted:
| „93679 | LEKOPTIN RETARD | tbl obd 20x240mg | LEK | SLO“. |
21. the following row 167.4 is inserted after row 167.3:
| „167.4 | C09DA01 | losartan v kombinaci s thiazidy | p.o. | 1 | DF | 33,40 | Z“. |
22. Line 215.3 reads:
| „215.3 | G03GA06 | folitrofin beta | parent. | 75 | U | 600,00 | Z“. |
23. the following row 215.5 is inserted after row 215.4:
| „215.5 | G03GA05 | folitrofin alfa | parent. | 75 | U | 600,00 | Z“. |
24. Row 222.1 reads:
| „222.1 | G04BC | rozpouštědla močových kamenů (ve formě prášku) | p.o. | 10 | GM | 6,15 | “. |
25. the following row 22.2 is inserted after row 22.1:
| „222.2 | G04BC | rozpouštědla močových kamenů (ve formě eff. tablet) | p.o. | 4 | DF | 6,15 | “. |
26. Line 254.11 reads:
| „254.11 | J01DA30 | cefapirin | parent. | 4 | GM | 199,20 | “. |
27. Row 260.9 reads:
| „260.9 | J01FA09 | klarithromycin (pevné lékové formy) | p.o. | 0.5 | GM | 72,25 | “. |
28. Row 260.10 reads:
| „260.10 | J01FA09 | klarithromycin (tekuté lékové formy) | p.o. | 0.5 | GM | 83,60 | “. |
29. Row 260.11 reads:
| „260.11 | J01FA10 | azithromycin (pevné lékové formy do 125 mg v 1 tabletě nebo tobolce včetně) | p.o. | 0.25 | GM | 94,50 | “. |
30. After row 260.11, entry 93590 is deleted:
| „93590 | SUMAMED | cps 6x250mg | PLI | CHO“. |
31. Line 260.14 reads:
| „260.14 | J01FA10 | azithromycin (pevné lékové formy nad 125 mg v 1 tabletě nebo tobolce) | p.o. | 0.25 | GM | 89,90 | “. |
32. the following entry 93590 is inserted after row 260.14:
| „93590 | SUMAMED | cps 6x250mg | PLI | CHO“. |
33. Row 278.1 reads:
| „278.1 | J04AC01 | isoniazid | p.o. | 0.3 | GM | 2,05 | “. |
34. Line 287.1 reads:
| „287.1 | J07AN01 | tuberkulosa, živé atenuované mykobakterium | parent. | 1 | DF | 260,70 | H“. |
35. the following row 288.4 is inserted after row 288.3:
| „288.4 | J07AX | jiné bakteriální vakcíny (uropatogenní vakcína) | parent. | 1 | DF | 286,90 | O“. |
36. Lines 350.1 and 350.2 read:
| „350.1 | M03AX01 | botulotoxin (do 100 U v jedné ampuli včetně) | parent. | 100 | U | 9800,- | X |
| 350.2 | M03AX01 | botulotoxin (nad 100 U v jedné ampuli) | parent. | 100 | U | 2500,- | X“. |
37. the following row 377.7 is inserted after row 377.6:
| „377.7 | N02BA | lysin acetylsalicylát v kombinaci s metoklopramidem | p.o. | 1 | DF | 17,- Kč | “. |
38. Line 396.3 reads:
| „396.3 | N03AX09 | lamotrigin (nad 5 mg do 50 mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 194,60 | L/PSY,NEU“. |
39. after row 396.3, entries 68802 and 84513 are deleted:
| „68802 | LAMICTAL | tbl 30x100mg | BWE | GB |
| 84513 | LAMICTAL 100MG DISPERSIBLE/CHEW | ctb 30x100mg | BWE | GB“. |
40. the following rows 396.6, 396.7 and 396.8 are inserted after row 396.5:
| „396.6 | N03AX09 | lamotrigin (nad 50 mg v jedné tabletě) | p.o. | 0.3 | GM | 161,- | L/PSY,NEU |
| 396.7 | N03AX11 | topiramat (do 25 mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 170,- | L/PSY,NEU |
| 396.8 | N03AX11 | topiramat (nad 25 mg v jedné tabletě) | p.o. | 0.3 | GM | 152,- | L/PSY,NEU“. |
41. Row 400.2 reads:
| „400.2 | N04BA02 | levodopa/karbidopa (do 125 mg v 1 tabletě včetně) | p.o. | 0.6 | GM | 33,65 | “. |
42. the following entry 45241 is inserted after row 400.2:
| „45241 | ISICOM 100MG | tbl 100x100mg | DET | D“. |
43. Row 400.3 reads:
| „400.3 | N04BA02 | levodopa/karbidopa (nad 125 mg v 1 tabletě) | p.o. | 0.6 | GM | 20,30 | “. |
44. After row 400.3, entry 03591 is deleted:
| „03591 | NAKOM | tbl 100x275mg | LEK | SLO“. |
45. the following entry 45244 is inserted after row 400.3:
| „45244 | ISICOM 250MG | tbl 100x250mg | DET | D“. |
46. the following entries 402.3, 402.4 and 402.5 are inserted after row 402.2:
| „402.3 | N04BC02 | pergolidi mexilas | p.o. | 3 | MG | 120,- | X |
| 402.4 | N04BC03 | dihydroergokriptin | p.o. | 10 | MG | 20,- | X |
| 402.5 | N04BC05 | pramipexol | p.o. | 3 | MG | 120,- | X“. |
47. Row 423.3 reads:
| „423.3 | N05BX01 | mefenoxalon | p.o. | 1.2 | GM | 16,80 | “. |
48. the following row 476.12 is inserted after row 476.11:
| „476.12 | S01AA | kanamycin lok. | lok. | 1 | ML | 3,10 | “. |
49. the following rows 487.4 and 487.5 are inserted after row 487.3:
| „487.4 | S01FA01 | atropin (koncentrace do 0,5% včetně) | lok. | 1 | ML | 5,30 | |
| 487.5 | S01FA01 | atropin (koncentrace nad 0,5%) | lok. | 1 | ML | 6,00 | “. |
50. Line 488.7 reads:
| „488.7 | S01GX03 | kyselina spaglumová | lok. | 1 | ML | 13,50 | L/OPH,ALG“. |
51. Line 492.1 reads:
| „492.1 | V01AA | extrakty alergenů (nestandardizované, bakteriální, z plísní, plná terapeutická dávka) | p.o. | 1 | BA | 919,- | L/ALG“. |
52. the following entries are deleted after row 492.1:
| „97141 | H-AL BACT.SEVAC P.O.PROTEUS V+M | sol 10000pnu 1x9ml | SEV | CZ |
| 97144 | H-AL BACT.SEVAC P.O.STREP.PNEU | sol 10000pnu 1x9ml | SEV | CZ |
| 98390 | H-AL BACT.SEVAC P.O.STAPH.AUR. | sol 10000pnu 1x9ml | SEV | CZ |
| 98393 | H-AL BACT.SEVAC P.O.HAEM.INFL. | sol 10000pnu 1x9ml | SEV | CZ |
| 98396 | H-AL BACT.SEVAC P.O.SMES HCD | sol 10000pnu 1x9ml | SEV | CZ |
| 98402 | H-AL BACT.SEVAC P.O.STA.+STR.PN | sol 10000pnu 1x9ml | SEV | CZ |
| 98405 | H-AL BACT.SEVAC P.O.STA.+HAEM.I | sol 10000pnu 1x9ml | SEV | CZ |
| 98408 | H-AL BACT.SEVAC P.O.STA.+NEIS.P | sol 10000pnu 1x9ml | SEV | CZ |
| 98411 | H-AL BACT.SEVAC P.O.SMES DCD | sol 10000pnu 1x9ml | SEV | CZ“. |
53. The following entries 97139, 97142, 97145, 98391, 98394, 98397, 98400, 98403, 98406, 98409, 98454, 98460 and 98457 are inserted after row 492.1:
| „97139 | H-AL BACT.SEVAC P.O.PROTEUS V+M | sol od 0.1pnu 6x9ml | SEV | CZ |
| 97142 | H-AL BACT.SEVAC P.O.STREP.PNEU | sol od 0.1pnu 6x9ml | SEV | CZ |
| 97145 | H-AL BACT.SEVAC P.O.STAPH.AUR. | sol od 0.1pnu 6x9ml | SEV | CZ |
| 98391 | H-AL BACT.SEVAC P.O.HAEM.INFL. | sol od 0.1pnu 6x9ml | SEV | CZ |
| 98394 | H-AL BACT.SEVAC P.O.SMES HCD | sol od 0.1pnu 6x9ml | SEV | CZ |
| 98397 | H-AL BACT.SEVAC P.O.SM.PROTIAKN | sol od 0.1pnu 6x9ml | SEV | CZ |
| 98400 | H-AL BACT.SEVAC P.O.STA.+STR.PN | sol od 0.1pnu 6x9ml | SEV | CZ |
| 98403 | H-AL BACT.SEVAC P.O.STA.+HAEM.I | sol od 0.1pnu 6x9ml | SEV | CZ |
| 98406 | H-AL BACT.SEVAC P.O.STA.+NEIS.P | sol od 0.1pnu 6x9ml | SEV | CZ |
| 98409 | H-AL BACT.SEVAC P.O.SMES DCD | sol od 0.1pnu 6x9ml | SEV | CZ |
| 98454 | H-AL MYCO SEVAC P.O.SMES KANDID | sol od 0.1pnu 6x9ml | SEV | CZ |
| 98460 | H-AL MYCO SEVAC P.O.SM.PL.DOMOV | sol od 0.1pnu 6x9ml | SEV | CZ |
| 98457 | H-AL MYCO SEVAC P.O.SM.PL.VENK. | sol od 0.1pnu 6x9ml | SEV | CZ“. |
54. Line 492.2 reads:
| „492.2 V01AA | extrakty alergenů (nestandardizované, bakteriální, z plísní, nejvyšší koncentrace) | p.o. | 1 | BA | 442,60 | L/ALG“. |
55. the following entries are deleted after row 492.2:
| „97139 | H-AL BACT.SEVAC P.O.PROTEUS V+M | sol od 0.1pnu 6x9ml | SEV | CZ |
| 97142 | H-AL BACT.SEVAC P.O.STREP.PNEU | sol od 0.1pnu 6x9ml | SEV | CZ |
| 97145 | H-AL BACT.SEVAC P.O.STAPH.AUR. | sol od 0.1pnu 6x9ml | SEV | CZ |
| 98391 | H-AL BACT.SEVAC P.O.HAEM.INFL. | sol od 0.1pnu 6x9ml | SEV | CZ |
| 98394 | H-AL BACT.SEVAC P.O.SMES HCD | sol od 0.1pnu 6x9ml | SEV | CZ |
| 98397 | H-AL BACT.SEVAC P.O.SM.PROTIAKN | sol od 0.1pnu 6x9ml | SEV | CZ |
| 98400 | H-AL BACT.SEVAC P.O.STA.+STR.PN | sol od 0.1pnu 6x9ml | SEV | CZ |
| 98403 | H-AL BACT.SEVAC P.O.STA.+HAEM.I | sol od 0.1pnu 6x9ml | SEV | CZ |
| 98406 | H-AL BACT.SEVAC P.O.STA.+NEIS.P | sol od 0.1pnu 6x9ml | SEV | CZ |
| 98409 | H-AL BACT.SEVAC P.O.SMES DCD | sol od 0.1pnu 6x9ml | SEV | CZ |
| 98454 | H-AL MYCO SEVAC P.O.SMES KANDID | sol od 0.1pnu 6x9ml | SEV | CZ |
| 98460 | H-AL MYCO SEVAC P.O.SM.PL.DOMOV | sol od 0.1pnu 6x9ml | SEV | CZ |
| 98457 | H-AL MYCO SEVAC P.O.SM.PL.VENK. | sol od 0.1pnu 6x9ml | SEV | CZ“. |
56. the following entries 97141, 97144, 98390, 98393, 98396, 98402, 98405, 98408 and 98411 are inserted after row 492.2:
| „97141 | H-AL BACT.SEVAC P.O.PROTEUS V+M | sol 10000pnu 1x9ml | SEV | CZ |
| 97144 | H-AL BACT.SEVAC P.O.STREP.PNEU | sol 10000pnu 1x9ml | SEV | CZ |
| 98390 | H-AL BACT.SEVAC P.O.STAPH.AUR. | sol 10000pnu 1x9ml | SEV | CZ |
| 98393 | H-AL BACT.SEVAC P.O.HAEM.INFL. | sol 10000pnu 1x9ml | SEV | CZ |
| 98396 | H-AL BACT.SEVAC P.O.SMES HCD | sol 10000pnu 1x9ml | SEV | CZ |
| 98402 | H-AL BACT.SEVAC P.O.STA.+STR.PN | sol 10000pnu 1x9ml | SEV | CZ |
| 98405 | H-AL BACT.SEVAC P.O.STA.+HAEM.I | sol 10000pnu 1x9ml | SEV | CZ |
| 98408 | H-AL BACT.SEVAC P.O.NEIS.P | sol 10000pnu 1x9ml | SEV | CZ |
| 98411 | H-AL BACT.SEVAC P.O.SMES DCD | sol 10000pnu 1x9ml | SEV | CZ“. |
57. Line 492.3 reads:
| „492.3 | V01AA | extrakty alergenů (nestandardizované, z hmyzu, z roztočů, plná terapeutická dávka pro pacienta) | p.o. | 1 | BA | 90% | L/ALG“. |
58. the following entries are deleted after row 492.3:
| „98444 | H-AL INS.SEVAC P.O.VCELI EXTR. | sol 5000pnu 1x9ml | SEV | CZ |
| 98453 | H-AL MIT.SEVAC P.O.SMES ROZTOCU | sol 10000pnu 1x9ml | SEV | CZ“. |
59. Line 492.4 reads:
| „492.4 | V01AA | extrakty alergenů (nestandardizované, z hmyzu, z roztočů, nejvyšší koncentrace) | p.o. | 1 | BA | 90% | L/ALG“. |
60. After row 492.4, the following entries are deleted:
| „98442 | H-AL INS.SEVAC P.O.VCELI EXTR. | sol od 0.5pnu 6x9ml | SEV | CZ |
| 98443 | H-AL INS.SEVAC P.O.VCELI EXTR. | sol od 0.05pnu 6x9 | SEV | CZ |
| 98446 | H-AL INS.SEVAC P.O.VOSI EXTR. | sol od 0.05pnu 6x9 | SEV | CZ |
| 98448 | H-AL INS.SEVAC P.O.VCEL+VOS.EXT | sol od 0.5pnu 6x9ml | SEV | CZ |
| 98449 | H-AL INS.SEVAC P.O.VCEL+VOS.EXT | sol od 0.05pnu 6x9 | SEV | CZ |
| 98451 | H-AL MIT.SEVAC P.O.SMES ROZTOCU | sol od 0.1pnu 6x9ml | SEV | CZ“. |
61. Row 492.5 reads:
| „492.5 | V01AA | extrakty alergenů (nestandardizované, z plísní, individuální alergeny) | p.o. | 1 | BA | 90% | L/ALG“. |
62. Row 492.6 reads:
| „492.6 | V01AA | extrakty alergenů (nestandardizované, z prachu obohacené, individuální alergeny) | p.o. | 1 | BA | 90% | L/ALG“. |
63. Line 492.7 reads:
| „492.7 | V01AA | extrakty alergenů (nestandardizované, z prachu, včetně obohacených, nejvyšší koncentrace) | p.o. | 1 | BA | 90% | L/ALG“. |
64. After row 492.7, entry 98432 is deleted:
Sign in for notes, favorites and notifications
Regulation Information
| Citation | Decree of the Ministry of Health No. 209 / 1998 Coll., amending Decree of the Ministry of Health No. 57 / 1997 Coll., which provides for medicinal products fully covered by health insurance and the amount of payments of individual active substances, as amended |
|---|---|
| Regulation Type | Order |
| Author | - |
| Collection | Code of Laws |
| Date of Promulgation | 07.09.1998 |
|---|---|
| Effective from | 01.10.1998 |
| Effective until | - |
| Status | Valid |
The regulation text is for informational purposes only.
Comments 0